Bortezomib Sensitizes Malignant Human Glioma Cells to TRAIL, Mediated by Inhibition of the NF-κB Signaling PathwayEsther P. Jane, Ian F. Pollack|Molecular Cancer Therapeutics|2011Cited by 75
Inhibition of Phosphatidylinositol 3-Kinase/AKT Signaling by NVP-BKM120 Promotes ABT-737–Induced Toxicity in a Caspase-Dependent Manner through Mitochondrial Dysfunction and DNA Damage Response in Established and Primary Cultured Glioblastoma CellsEsther P. Jane, Ian F. Pollack|Journal of Pharmacology and Experimental Therapeutics|2014Cited by 35
Abrogation of Mitogen-Activated Protein Kinase and Akt Signaling by Vandetanib Synergistically Potentiates Histone Deacetylase Inhibitor-Induced Apoptosis in Human Glioma CellsEsther P. Jane, Ian F. Pollack|Journal of Pharmacology and Experimental Therapeutics|2009Cited by 27
Reversing tozasertib resistance in glioma through inhibition of pyruvate dehydrogenase kinasesEsther P. Jane, Ian F. Pollack|Molecular Oncology|2021Cited by 23
Targeting mitochondrial energetics reverses panobinostat‐ and marizomib‐induced resistance in pediatric and adult high‐grade gliomasEsther P. Jane, Ian F. Pollack|Molecular Oncology|2023Cited by 12